Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
multiple sclerosis
Fierce Biotech
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Less than two weeks after rejecting Sanofi’s investigational MS drug, the FDA has shared the CRL, citing both efficacy and safety concerns.
Gabrielle Masson
Jan 6, 2026 4:30am
Genentech uncovers 'Hidden GeMS' in latest #MSVisibility drive
Dec 9, 2025 4:05pm
Sandoz's biosimilar to Biogen's Tysabri hits the US after delay
Nov 17, 2025 11:12am
Biogen ticks up sales outlook again as MS franchise holds strong
Oct 30, 2025 1:37pm
Fierce Biotech
Diabetes drug soothes brain inflammation in female mice with MS
Oct 15, 2025 6:16pm
Zenas gains MS hopeful in $2B deal with China's InnoCare
Oct 8, 2025 11:50am
